Literature DB >> 31883216

Controlled attenuation parameter by vibration-controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging-based proton density fat fraction.

Qiang Zeng1, Zhenya Song2, Yi Zhao2, Jianjun Wu1, Liuhong Wang3, Huiyi Ye4, Yingwei Wang4, Ting Wu5, Sishu Yuan6, Haojie Yuan2.   

Abstract

AIM: Controlled attenuation parameter (CAP) measured by vibration-controlled transient elastography (FibroScan) allows repeatable and reliable assessment of liver steatosis for screening of patients at risk of non-alcoholic steatohepatitis development among asymptomatic individuals at a community level. However, this has never been compared with another quantitative method, such as magnetic resonance imaging-based proton density fat fraction, among the Chinese health checkup population.
METHODS: A multicenter prospective study was conducted with Chinese individuals undergoing regular health checkups. Steatosis grading by magnetic resonance imaging-based proton density fat fraction was used as the reference to evaluate the diagnostic performance of CAP.
RESULTS: A total of 173 individuals were included with mean age of 45 ± 11 years and body mass index of 25.8 ± 4.0 kg/m2 . A linear correlation was found between CAP and log10 -transformed magnetic resonance imaging-based proton density fat fraction results (Pearson's coefficient 0.772, P < 0.001). The areas under the receiver operating characteristic curve for distinguishing ≥S1 and ≥S2 steatosis were 0.88 (95% confidence interval 0.83-0.93) and 0.89 (95% confidence interval 0.83-0.95), respectively. When optimized for ≥90% sensitivity, the CAP cut-off for staging ≥S1 steatosis was 244 dB/m. CAP could classify patients with ≥S1 steatosis with similar performance as an ultrasound examination.
CONCLUSIONS: As a non-invasive and quantitative method, CAP is highly adapted for population screening at a community level. With the integration of liver stiffness and CAP results in risk stratification scores for non-alcoholic steatohepatitis, vibration-controlled transient elastography can be useful in regular health checkups.
© 2019 The Japan Society of Hepatology.

Entities:  

Keywords:  FibroScan; controlled attenuation parameter; non-alcoholic fatty liver disease; non-invasive assessment

Year:  2020        PMID: 31883216     DOI: 10.1111/hepr.13481

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  3 in total

Review 1.  Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease.

Authors:  Nobuharu Tamaki; Masayuki Kurosaki; Yutaka Yasui; Kaoru Tsuchiya; Namiki Izumi
Journal:  J Med Ultrason (2001)       Date:  2021-06-24       Impact factor: 1.314

2.  Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Anusha Vittal; Mark Shapses; Bashar Sharma; Disha Sharma; Qian Sun; Maureen Sampson; Wilson Lee; Gil Ben Yakov; Yaron Rotman
Journal:  Hepatol Commun       Date:  2020-12-29

Review 3.  Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?

Authors:  Roxana Sirli; Ioan Sporea
Journal:  Can J Gastroenterol Hepatol       Date:  2021-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.